Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$1.6 million.

  • Rockwell Medical's Free Cash Flow fell 138.83% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 213.32%. This contributed to the annual value of $3.2 million for FY2024, which is 132.91% up from last year.
  • As of Q3 2025, Rockwell Medical's Free Cash Flow stood at -$1.6 million, which was down 193.68% from $1.7 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Free Cash Flow high stood at $4.1 million for Q3 2024, and its period low was -$12.5 million during Q1 2021.
  • Over the past 3 years, Rockwell Medical's median Free Cash Flow value was -$1.6 million (recorded in 2025), while the average stood at -$905,545.
  • Its Free Cash Flow has fluctuated over the past 5 years, first slumped by 268.79% in 2023, then skyrocketed by 646.51% in 2024.
  • Rockwell Medical's Free Cash Flow (Quarterly) stood at -$9.1 million in 2021, then spiked by 95.70% to -$393,000 in 2022, then skyrocketed by 78.12% to -$86,000 in 2023, then skyrocketed by 646.51% to $470,000 in 2024, then tumbled by 138.83% to -$1.6 million in 2025.
  • Its Free Cash Flow stands at -$1.6 million for Q3 2025, versus $1.7 million for Q2 2025 and -$3.6 million for Q1 2025.